HIV, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Five-Year Enacted Funding History
FY2018 - FY2022 funding reflects enacted1 amounts.
FY 2018 and FY 2019 enacted amounts are adjusted to reflect $7.222 million realignment from Tuberculosis in the HIV, Viral Hepatitis, STI and TB Prevention account to Global Tuberculosis in the Global Health account.
FY 2019 - FY 2022 enacted amounts includes funding for Infectious Diseases and the Opioid Epidemic.
1 Enacted: The amount in the spending bill passed by both chambers of Congress and made into law.
HIV, Viral Hepatitis, Sexually Transmitted Infections, and Tuberculosis Five-Year Enacted Funding History (dollars in thousands)
| Fiscal Year | Enacted Amounts |
|---|---|
| FY 2018 | $1,120,056 |
| FY 2019 | $1,125,056 |
| FY 2020 | $1,273,556 |
| FY 2021 | $1,314,056 |
| FY 2022 | $1,345,056 |
How is CDC funding used for HIV, Viral Hepatitis, STIs, TB Prevention?
In FY 2022, the U.S. Congress enacted a spending bill that appropriated $1,345,056,000 to CDC to prevent and control HIV, viral hepatitis, STIs, TB, infectious diseases and the opioid epidemic, and to promote adolescent and school health. The FY 2022 operating budget2 amount was $1,242,862,946:
- Approximately 75% of the operating budget was awarded through extramural mechanisms. The majority of this funding is awarded to state, tribal, local, and territorial health departments, community-based organizations, national organizations, academic institutions, and education agencies as grants and cooperative agreements.
- Approximately 25% of the operating budget was spent on internal CDC resources that enable the nation’s response to infectious disease, including world-class laboratories, outbreak response, cutting-edge research, and technical assistance to health departments and community-based organizations.
These expenditures achieved measurable reduction in risk factors, illness, and death in communities at all levels of social status.
2Operating budget: Amount of funding obligated by an organization during the fiscal year to meet both routine business costs and program needs.
Domestic HIV Prevention and Research, Viral Hepatitis, Sexually Transmitted Infections, and Tuberculosis FY2022 Operating Budget
| Expenditure Type | Amount |
|---|---|
| Extramural | 75% |
| Intramural | 25% |
| Total | $1,242,862,946 |
The funding data and state summaries provided were developed based on fiscal year (FY) 2022 actual spending. The data include actions awarded (i.e., obligated funds) domestically in federal FY 2022 (October 1, 2021 to September 30, 2022) from CDC’s annual appropriation. The funding data are categorized by CDC’s budget line as shown in the operating plans. The data represent a point in time and may not reflect CDC’s total appropriations in any given area.
- CDC Budget Information (including Annual President’s Requests)
- Department of Health and Human Services (HHS) Budget Information
- Office of Management and Budget (OMB) Budget Information
